CODE AQ
This is an online Blog book to discuss our patients deidentified health data shared after taking his/ her guardians to sign an informed consent
Here we discuss our patient problems through a series of inputs from the available Global online community of experts with n aim to solve those patient clinical problems with the current best evidence-based input
This Blog also reflects my patient-centred online learning portfolio.
Your valuable input on the comment box is welcome
I have been given this case to solve in an attempt to understand the topic of " Patient clinical data analysis" to develop my competence in reading and comprehending clinical data including history, clinical findings, and investigations and coming up with a diagnosis and treatment plan.
DEIDENTIFIED DISCHARGE SUMMARY
PID 202243463
JUHID : 20221023236
Pay Type
Credit (AROGYA SREE)
Age/Gender: 66 Years/Male
Address
Discharge Type: Relieved
Admission Date: 17/10/2022 11:02 AM
Name of Treating Faculty
DR.SRI RAMULU
Diagnosis
CKD ON MHD
Case History and Clinical Findings
C/O DECAREASED URINE OUTPUT SINCE 3 DAYS
SOB SINCE 3DAYS
PT WAS APPARENTLY ASYMPTOMATIC 3 DAYS BACK THEN HE DEVELOPED C/O DECREASED URINE OUTPUT SINCE 3 DAYS ASSOCIATED WITH SOB SINCE 3 DAYS WHICH IS INSIDIOUS IN ONSET, GRADUALLY PROGRESSIVE TO MMRC GRADE 4
NO CIO BURNING MICTURITION AND PEDAL EDEMA, FEVER
PERSONAL HISTORY: HTN, DM +
DIET MIXED
APPETITE:NORMAL
BOWEL HABITS REGULAR
DECREASED URINE OUTPUT
ADDICTIONS: NONE
FAMILY HISTORY INSIGNIFICANT
GENERAL EXAMINATION:
PT IS C/CIC
WELL ORIENTED TO TIME, PLACE AND PERSON
VITALS:
TEMP. 98
BP:140/80 MMHG
PR: 78 BPM
SPO2: 98%
SYSTEMIC EXAMINATION:
CVS: S1, S2 HEARD
RS: BAE+
CNS: NFND
PIA: SOFT, NT, BS+
Investigation
CBP
HB 10.4
TC 7400
PLT 1.50
SMEAR NONC
RFT
UR 79
CR 4.4
HIV NEGATIVE
HBSAG NEGATIVE
HCV NEGATIVE
USG
B/L GRADE 3 RPD CHANGES
2D ECHO
DILATED RA
DILATEDE LA
EF 56%, GOOD LV FUNCTON
GRADE I DIASTOLIC DYSFUNCTION
MODERATE AR, MILD TR, MILD MR. NO AS/MS
NO PE/ LV CLOT
Treatment Given(Enter only Generic Name)
1)SALT RESTRICTION LESS THAN 2.4 GM/DAY
2) FLUID RESTRICTION LESS THAN ILTRIDAY
3)TAB TELMA 80 PO/OD
4)TAB SHELCAL PO/BD
5)TAB OROFER XT PO/OD
6)TAB LASIX40 MG/PO/BD
7)INJ ERYTHROPOIETIN 4000 IU S/C AFTER EACH DIALYSIS
8)TAB BIOP3 WEEKLY ONCE
9)TAB NICARDIA 20 MG PO/TID
10)TAB ARKAMINE 0.1 MG PO/TID
11) INJ. IRON SUCROSE 100 MG ONCE WEEKLY
Advice at Discharge
1)SALT RESTRICTION LESS THAN 2.4 GM/DAY
2)FLUID RESTRICTION LESS THAN 1 LTR/DAY
3)TAB TELMA 80 PO/OD
4)TAB SHELCAL PO/BD
SITAS OROFER XT PO/OD
6)TAB LASIX40 MG/PO/BD
7)INJ ERYTHROPOIETIN 4000 IU S/C AFTER EACH DIALYSIS
8)TAS BIOP3 WEEKLY ONCE
9)TAB NICARDIA 20 MG PO/TID
10)TAB ARKAMINE 0.1 MG PO/TID
11) INJ. IRON SUCROSE 100 MG ONCE WEEKLY
Follow Up
REVIEW TO NEPHRO OP AFTER 1 WEEK
When to Obtain Urgent Care
IN CASE OF ANY EMERGENCY IMMEDIATELY CONTACT YOUR CONSULTANT DOCTOR OR ATTEND EMERGENCY DEPARTMENT.
Preventive Care
AVOID SELF MEDICATION WITHOUT DOCTORS ADVICE, DONOT MISS MEDICATIONS. In case of Emergency or to speak to your treating FACULTY or For Appointments, Please Contact: 05682279999 For Treatment Enquiries Patient/Attendent Declaration: The medicines prescribed and the advice regarding preventive aspects of care when and now to oblain urgent care have been explained to me in my own language
SIGNATURE OF PATIENT ATTENDER
SIGNATURE OF PG/INTERNEE
SIGNATURE OF ADMINISTRATOR
SIGNATURE OF FACULTY
Discharge Date
Date:23-11-22
Ward: CKD WARD
Unit: NEPHROLOGY
Comments
Post a Comment